Alkermes vs PACS Group
Alkermes (ALKS), health care, and PACS Group (PACS), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Alkermes and PACS Group are valued at about the same: $7.6B and $7.7B. Alkermes's operating margin in its latest fiscal year was 17.2% and PACS Group's 5.85%. Over the past year Alkermes's share price has moved +59.0% and PACS Group's +240%.
Key facts
- Alkermes market value
- $7.6B
- PACS Group market value
- $7.7B
- PACS Group P/E
- 27.6
- Alkermes revenue
- $1.5BFY to 2025-12-31
- PACS Group revenue
- $5.3BFY to 2025-12-31
- Superinvestors holding both
- 0
Market values as of .
| Measure | Alkermes | PACS Group |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $7.6Blower | $7.7Bhigher |
| Revenue | $1.5Blower | $5.3Bhigher |
| Earnings | $241.7Mhigher | $191.5Mlower |
| Employees | 2,050lower | 47,455higher |
| Total assets | $2.5Blower | $5.6Bhigher |
| Valuation | ||
| P/E | — | 27.6 |
| P/S | 5.2higher | 1.5lower |
| P/B | — | 6.3 |
| Dividend yield | — | 0.00% |
| Profitability | ||
| Operating margin | 17.2%higher | 5.85%lower |
| Balance sheet | ||
| Net assets | $1.8Bhigher | $946.8Mlower |
| Total liabilities | $667.7Mlower | $4.6Bhigher |
| Total debt | — | $353.2M |
| Cash on hand | $388.6Mhigher | $197Mlower |
| Price change | ||
| Today | -2.32%lower | -0.92%higher |
| 1 year | +59.0%lower | +240%higher |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (0)
None of the tracked investors.
Alkermes only (4)
PACS Group only (1)
Percentages are each holding's share of that investor's reported portfolio. Who owns ALKS · Who owns PACS
More on Alkermes
Further comparisons
Alkermes against its closest peers
PACS Group against its closest peers
Learn
Questions and answers
Which is bigger, Alkermes or PACS Group?
By market value, PACS Group is the larger: $7.7B against $7.6B for Alkermes. By revenue in its latest fiscal year, PACS Group is the larger: $5.3B against $1.5B for Alkermes.
Which has the higher operating margin?
Alkermes: 17.2%, against 5.85% for PACS Group. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which superinvestors own both Alkermes and PACS Group?
None of the tracked superinvestors holds both in their latest 13F filing. 4 hold Alkermes and 1 holds PACS Group.
Cite this page
Funkfolio, “Alkermes vs PACS Group”, data as of 17 November 2026. https://funkfolio.com/compare/alks-vs-pacs
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.